← All trials
NCT00804154
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 3, 2008
- Primary completion
- Jun 30, 2020
- Completion date
- Dec 30, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 13
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- National Institute of Dental and Craniofacial Research (NIDCR)Lead sponsor
- National Institute of Neurological Disorders and Stroke (NINDS)Overall official - principal investigator
- National Institute of Neurological Disorders and Stroke (NINDS)Collaborator
- Sorrento Therapeutics, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.